Limpar
792 resultados

Acesso aberto

Tipo do recurso

Ano de criação

Produção nacional

Revisado por pares

Áreas

Idioma

Editores

Revisão Revisado por pares

Michael F. Holick,

... Form,1,25-Dihydroxy vitamin D3 MICHAEL F. HOLICK, MICHAEL F. HOLICK Boston University School of Medicine M-1013 ... for more papers by this author MICHAEL F. HOLICK, MICHAEL F. HOLICK Boston University School of Medicine M-1013 Vitamin ...

Tópico(s): Retinoids in leukemia and cellular processes

1988 - Wiley | Annals of the New York Academy of Sciences

Artigo Acesso aberto Revisado por pares

Michael F. Holick,

... D and Its Consequences for Humans† MICHAEL F. HOLICK, MICHAEL F. HOLICK Vitamin D Laboratory, Endocrine Unit Massachusetts General ... for more papers by this author MICHAEL F. HOLICK, MICHAEL F. HOLICK Vitamin D Laboratory, Endocrine Unit Massachusetts General Hospital ...

Tópico(s): Skin Protection and Aging

1985 - Wiley | Annals of the New York Academy of Sciences

Artigo Revisado por pares

Thomas L. Clemens, Noboru Horiuchi, Minh Van Nguyen, Michael F. Holick,

... USASearch for more papers by this authorMichael F. Holick, Michael F. Holick Vitamin D Laboratory, Endocrine Unit, Massachusetts General ... USASearch for more papers by this authorMichael F. Holick, Michael F. Holick Vitamin D Laboratory, Endocrine Unit, Massachusetts General Hospital ...

Tópico(s): Effects and risks of endocrine disrupting chemicals

1981 - Wiley | FEBS Letters

Artigo Acesso aberto Revisado por pares

John S. Adams, Thomas L. Clemens, Noboru Horiuchi, Andrea Quaroni, Michael F. Holick,

... USASearch for more papers by this authorMichael F. Holick, Michael F. Holick Vitamin D Laboratory, Endocrine Unit, Massachusetts General ... USASearch for more papers by this authorMichael F. Holick, Michael F. Holick Vitamin D Laboratory, Endocrine Unit, Massachusetts General Hospital, ...

Tópico(s): Receptor Mechanisms and Signaling

1982 - Wiley | FEBS Letters

Artigo Revisado por pares

S. A. Holick, Michael F. Holick, Jane Frommer, John W. Henley, Judith A. Lenz, John T. Potts,

... D3 and its metabolism in the ratSally A. Holick, Michael F. Holick, Jane E. Frommer, John W. Henley, Judith A. ...

Tópico(s): Vitamin K Research Studies

1980 - American Chemical Society | Biochemistry

Artigo Revisado por pares

Rahul Ray, Stanley Rose, S. A. Holick, Michael F. Holick,

We evaluated the viability of 1α,25-dihydroxyvitaminD3-3β-[N-(4-azido-2-nitrophenyl)glycinate] (1,25-(OH)2-D3-ANG), an analog of 1α,25-dihydroxyvitamin D3 (1,25-(OH)2-D3) as a photoaffinity probe for 1,25-(OH)2-D3 receptor in chick intestinal cytosol. A competitive-binding assay revealed that chick intestinal cytosolic 1,25-(OH)2- D3 receptor bound to 1,25-(OH)2-D3-ANG approximately 20-times less effectively than it did to 1,25-(OH)2-D3. Irradiation of 1,25-(OH)2-D3- ANG in the presence of chick intestinal ...

Tópico(s): Estrogen and related hormone effects

1985 - Elsevier BV | Biochemical and Biophysical Research Communications

Artigo

Rahul Ray, S. A. Holick, Michael F. Holick,

R. Ray, S. A. Holick and M. F. Holick, J. Chem. Soc., Chem. Commun., 1985, 702 DOI: 10.1039/C39850000702

Tópico(s): Fluorine in Organic Chemistry

1985 - Royal Society of Chemistry | Journal of the Chemical Society Chemical Communications

Artigo Acesso aberto Revisado por pares

Edward P. Amento, A K Bhalla, J T Kurnick, Richard L. Kradin, T. L. Clemens, S. A. Holick, Michael F. Holick, Stephen M. Krane,

The monocyte factor, interleukin 1, or other factors homologous with interleukin 1, modulates functions of a variety of cells, including T and B lymphocytes, synovial cells, and chondrocytes. We have reported that a human monocyte cell line, U937, produces interleukin 1 when incubated with a soluble factor from lectin-stimulated T lymphocytes. We have also shown that U937 cells have a specific cytosolic receptor for 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25[OH]2D3). We now report that 1 alpha,25( ...

Tópico(s): Cytokine Signaling Pathways and Interactions

1984 - American Society for Clinical Investigation | Journal of Clinical Investigation

Artigo Revisado por pares

S. A. Holick, Michael F. Holick, Julia A. MacLaughlin,

Tópico(s): Growth Hormone and Insulin-like Growth Factors

1980 - Elsevier BV | Biochemical and Biophysical Research Communications

Artigo Acesso aberto Revisado por pares

S. A. Holick, Michael F. Holick, T E Tavela, Heinrich K. Schnoes, Hector F. DeLuca,

Chicks convert both orally and intravenously administered 1alpha-hydroxy[6-3H]vitamin D3 rapidly to 1alpha,25-dihydroxy[6-3H]vitamin D3. The maximal accumulation of 1alpha,25-dihydroxy[6-3H]vitamin D3 in intestine precedes the intestinal absorption response to 1alpha-hydroxyvitamin D3 by at least 2 hours. Oral administration results in the highest concentrations of 1alpha,25-dihydroxy[6-3H]vitamin D3 in intestine, giving a level about 1.5 times that achieved with an intravenous dose. On the other ...

Tópico(s): Growth Hormone and Insulin-like Growth Factors

1976 - Elsevier BV | Journal of Biological Chemistry

Revisão Acesso aberto Revisado por pares

Tae‐Kang Kim, Radomir M. Slominski, Elżbieta Pyza, Konrad Kleszczyński, Robert C. Tuckey, Rüssel J. Reiter, Michael F. Holick, Andrzej Słomiński,

Melatonin, a product of tryptophan metabolism via serotonin, is a molecule with an indole backbone that is widely produced by bacteria, unicellular eukaryotic organisms, plants, fungi and all animal taxa. Aside from its role in the regulation of circadian rhythms, it has diverse biological actions including regulation of cytoprotective responses and other functions crucial for survival across different species. The latter properties are also shared by its metabolites including kynuric products generated ...

Tópico(s): Human Health and Disease

2024 - Wiley | Biological reviews/Biological reviews of the Cambridge Philosophical Society

Artigo Revisado por pares

Joseph Zimmerman,

... of 1,25 Dihydroxyvitamin DJOSEPH ZIMMERMAN, M.D., MICHAEL F. HOLICK, Ph.D., M.D., JUSTIN SILVER, M.D., ... D.Search for more papers by this author, MICHAEL F. HOLICK, Ph.D., M.D.Search for more papers ...

Tópico(s): Thyroid Cancer Diagnosis and Treatment

1983 - American College of Physicians | Annals of Internal Medicine

Artigo Revisado por pares

Rahul Ray, S. A. Holick, Nancy M. Hanafin, Michael F. Holick,

... azido-2-nitrophenyl)glycinate]Rahul Ray, Sally Ann Holick, Nancy Hanafin, and Michael F. HolickCite this: Biochemistry 1986, 25, 17, 4729–4733Publication ...

Tópico(s): Vitamin C and Antioxidants Research

1986 - American Chemical Society | Biochemistry

Artigo Revisado por pares

Michael F. Holick, Farhad Chimeh, S Ray,

... Albany Street, Boston, MA 02118, U.S.A Michael F.Holick. E‐mail: mfholick@bu.edu Search for other ...

Tópico(s): Growth Hormone and Insulin-like Growth Factors

2003 - Oxford University Press | British Journal of Dermatology

Carta Acesso aberto Revisado por pares

Andrzej Słomiński, Radomir M. Slominski, Paul A. Goepfert, Tae‐Kang Kim, Michael F. Holick, Anton M. Jetten, Chander Raman,

... M. Slominski, Paul A. Goepfert, Tae-Kang Kim, Michael F. Holick, Anton M. Jetten, and Chander RamanAndrzej T. SlominskiDepartment ...

Tópico(s): COVID-19 Clinical Research Studies

2020 - American Physiological Society | AJP Endocrinology and Metabolism

Artigo Revisado por pares

D. Diesing, Jörg Reichrath, Tai C. Chen, John N. Flanagan, Vin Tangpricha, K. Diedrich, Michael F. Holick, Michael Friedrich,

806

Tópico(s): Cancer, Hypoxia, and Metabolism

2005 - Lippincott Williams & Wilkins | Journal of Clinical Oncology

Artigo Acesso aberto Revisado por pares

Tai C. Chen, Xue Hong Zhu, Michael T. Holick, Xiangfu Kong, Michael F. Holick, John N. Flanagan, Lyman W. Whitlatch,

1α,25-Dihydroxyvitamin D3 (1α,25(OH)2D3) and its analogs are used to treat psoriasis because of their potent antiproliferative activity. They have the potential for causing hypercalcemia, however, and patients often become resistant to the drug. We examined the feasibility of enhancing the cutaneous production of 1α,25(OH)2D3 using a human 25-hydroxyvitamin D-1α-hydroxylase (1α-OHase) plasmid. The 1α-OHase gene was fused to the green fluorescent protein gene (1α-OHase-GFP) driven by the cytomegalovirus ...

Tópico(s): Dermatology and Skin Diseases

2001 - Elsevier BV | Journal of Investigative Dermatology

Editorial Acesso aberto Revisado por pares

Michael F. Holick,

... and cancer: Is there a D-lightful connection?† Michael F. Holick, Corresponding Author Michael F. Holick [email protected] Section of Endocrinology, Diabetes and Nutrition, ... MA 02118Search for more papers by this author Michael F. Holick, Corresponding Author Michael F. Holick [email protected] Section of Endocrinology, Diabetes and Nutrition, ...

Tópico(s): Endometriosis Research and Treatment

2009 - Wiley | American Journal of Hematology

Artigo Revisado por pares

Susan Sullivan, J. L. Cobb, Clifford J. Rosen, Michael F. Holick, Taofeng Chen, Michael G. Kimlin, Alfio V. Parisi,

Abstract The objective was to test a method of assessing sun exposure for use in stratifying adolescent girls according to potential for vitamin D 3 synthesis in the skin. Thirty-five girls wore polysulphone ultraviolet (UV) dosimeters and kept diaries of their activities on August 17, 2000. Minutes spent outdoors during each hour of the day were tabulated and adjusted for the fractional strength of ultraviolet B (UVB) radiation relative to peak hour. Total adjusted minutes outdoors were compared ...

Tópico(s): Climate Change Communication and Perception

2003 - Elsevier BV | Nutrition Research

Revisão Revisado por pares

Ronald C. Hamdy, Charles H. Chesnut, Margery Gass, Michael F. Holick, Edward S. Leib, Michael Lewiecki, Michael Maricic, Nelson B. Watts,

This review summarizes and updates data presented at recent annual Southern Medical Association conferences on postmenopausal osteoporosis. As part of any osteoporosis treatment program, it is important to maintain adequate calcium and 25-hydroxyvitamin D levels either through diet or supplementation. Among the available pharmacologic therapies, the bisphosphonates alendronate and risedronate have demonstrated the most robust fracture risk reductions-approximately 40 to 50% reduction in vertebral ...

Tópico(s): Vitamin D Research Studies

2005 - Lippincott Williams & Wilkins | Southern Medical Journal

Artigo Revisado por pares

Noboru Horiuchi, Michael F. Holick, John T. Potts, Michael Rosenblatt,

A synthetic analog of bovine parathyroid hormone (bPTH), [tyrosine-34]bPTH-(7-34)NH 2 , was found to inhibit parathyroid hormone action in vivo. When the analog and parathyroid hormone were infused simultaneously to rats at a molar ratio of 200 to 1, the analog inhibited the excretion of urinary phosphate and adenosine 3′,5′-monophosphate. When infused alone at the same dose rate, the analog was devoid of agonist activity. The compound was prepared by following design principles developed for inhibitors ...

Tópico(s): Fibroblast Growth Factor Research

1983 - American Association for the Advancement of Science | Science

Artigo Revisado por pares

John P. Bilezikian, Lynn B. Bailey, Patricia J. Elmer, Murray J. Favus, Vay Liang W. Go, Steven R. Goldring, Linda Hughey Holt, Karl Insogna, Barbara Kivimae Krimgold, Lawrence E. Mallette, Jay R. Shapiro, Sachiko T. St. Jeor, Paula H. Stern, Barbara C. Tilley, Monica E. Yamamoto, Steven A. Abrams, Alberto Ascherio, John A. Baron, Norman H. Bell, Elizabeth A. Chrischilles, Bess Dawson‐Hughes, Robert P. Heaney, Michael F. Holick, C. Conrad Johnston, Michael Kleerekoper, Jacob Lemann, Richard J. Levine, Robert S. Lindsay, Anne C. Looker, B Love, Robert Marcus, Velimir Matkovic, L. Joseph Melton, Pierre J. Meunier, Juan M. Navia, Dorothy A. Nelson, Eric Orwoll, William A. Peck, Robert R. Recker, Lawrence M. Resnick, B. Lawrence Riggs, Frederick R. Singer, Charles W. Slemenda, MaryFran Sowers, Connie M. Weaver, Sanford A. Miller, Walter C. Willett, Lawrence Shulman, Elia Ben-Ari, Elsa A. Bray, Mona S. Calvo, Nancy D. Ernst, John H. Ferguson, Gilman D. Grave, John G. Haddad, William H. Hall, Stephen P. Heyse, Van S. Hubbard, Joan McGowan, Marjorie Perloff, Ellyn J. Pollack, Maryann Reford, Pamela E. Stark-Reed,

IT HAS BEEN a decade since the 1984 Consensus Development Conference on Osteoporosis first suggested that increased intake of calcium might help prevent osteoporosis. Osteoporosis affects more than 25 million people in the United States and is the major underlying cause of bone fractures in postmenopausal women and the elderly. Previous surveys have revealed that the US population experiences more than 1.5 million fractures annually at a cost in excess of $10 billion per year to the health care system. ...

Tópico(s): Bone health and osteoporosis research

1994 - American Medical Association | JAMA

Artigo Revisado por pares

Todd E. Falcone, Dan J. Stein, Jeffrey S. Jumaily, Elizabeth N. Pearce, Michael F. Holick, David McAneny, Scharukh Jalisi, Gregory A. Grillone, Michael D. Stone, Anand K. Devaiah, J. Pieter Noordzij,

Objective: To examine the relationship between pre-operative vitamin D status and post-thyroidectomy hypocalcemia.

Tópico(s): Intestinal and Peritoneal Adhesions

2014 - Elsevier BV | Endocrine Practice

Artigo Revisado por pares

John C. Dowdy, Robert M. Sayre, Michael F. Holick,

Tópico(s): Vitamin C and Antioxidants Research

2010 - Elsevier BV | The Journal of Steroid Biochemistry and Molecular Biology

Artigo Acesso aberto Revisado por pares

William G. Christen, Nancy R. Cook, JoAnn E. Manson, Julie E. Buring, I‐Min Lee, Vadim Bubes, Georgina Friedenberg, Rimma Dushkes, Douglas A. Smith, Debra A. Schaumberg, JoAnn M. Manson, Julie E. Buring, Nancy R. Cook, I‐Min Lee, William G. Christen, Shari S. Bassuk, Samia Mora, Heike Gibson, David Gordon, Trisha Copeland, Denise D’Agostino, Georgina Friedenberg, Clair Ridge, Vadim Bubes, Edward L. Giovannucci, Walter C. Willett, John A. Baron, Michael F. Holick, Bruce W. Hollis, Christine M. Albert, Diane R. Gold, Meryl S. LeBoff, Olivia I. Okereke, Aruna D. Pradhan, Howard D. Sesso, Wendy Chen, Paulette D. Chandler, J. Michael Gaziano, Olga Demler, Kathryn M. Rexrode, Karen H. Costenbader, John P. Forman, Erik K. Alexander, Sonia Friedman, Jeffrey N. Katz, Shumin Zhang, Jennifer Lin, Joseph Walter, Julie Duszlak, Kate Kalan, Jean MacFadyen, Natalya Gomelskaya, David W. Bates, Ara Sarkissian, Mary Breen, Yeulolani Andrade, Manickavasagar Vinayagamoorthy, Chunying Li, Eun‐Jung Kim, Franco Giulianini, Gregory Kotler, Marty Van Denburgh, Rimma Dushkes, Yanyan Liu, Eduardo Pereira, Lisa Fields Johnson, George Menjin, Lucy Liu, Lauren Girard, Scott L. Zeller, Naomi O. Riches, Katelyn Hasson, Ellen Bhang, Maria Revilla, Elena McCarthy, Alex Moran, Kristen Halse, L. Arsenault, Philomena Quinn, Sancia Grimes, Ivan Fitchorov, Kurt Schwerin, Shamikhah Curry, Annie Murray, Angela Zhang, Diana Walron-Williams, Alison Weinberg, Chris Pfeffer, Margaret Haubourg, Viviane Nguyen, Henry Ouellette, Rolando Rodríguez, Tony Montgomery, Keith Morse, Vincent Guzman, Megan A. Perry, Sandra Weekes, Doug Smith, Allison Clar, Sara R. Curran, Yaneve N. Fonge, David Brynn Hibbert, Louisa Paine, Kelly Royce, Courtney Splaine, Jennifer A. McMahon, David Eldridge, Laura C. Hand, Kay Inandan, Meghan RieuWerden, Harriet Samuelson, Andrea Hrbek, Megan Mele, Eileen Bowes, Mary Anne Ryan, Carlos A. Camargo, Jacqueline S. Danik, Ravi Thadhani, Thomas J. Wang, Raj C. Shah, Michelle A. Albert,

Importance Results of several small randomized clinical trials have suggested that supplements of marine ω-3 fatty acids may be beneficial in treating signs and symptoms of dry eye disease (DED). However, randomized clinical trial data to examine whether ω-3 fatty acid supplements can prevent DED are lacking. Objective To evaluate whether long-term daily supplementation with marine ω-3 fatty acids prevents the development of DED. Design, Setting, and Participants This was a prespecified ancillary study of ...

Tópico(s): Seaweed-derived Bioactive Compounds

2022 - American Medical Association | JAMA Ophthalmology

Artigo Revisado por pares

Charles G. Gegick, T. S. Danowski, Hector F. De Luca, Michael F. Holick,

... C.P., HECTOR F. DE LUCA, M.D., MICHAEL F. HOLICK, M.D.CHARLES G. GEGICK, M.D.Search ... D.Search for more papers by this author, MICHAEL F. HOLICK, M.D.Search for more papers by this ...

Tópico(s): Blood disorders and treatments

1974 - American College of Physicians | Annals of Internal Medicine

Revisão Acesso aberto Revisado por pares

Michael F. Holick,

The discovery of a fat-soluble nutrient that had antirachitic activity and no vitamin A activity by McCollum has had far reaching health benefits for children and adults. He named this nutrient vitamin D. The goal of this review and personal experiences is to give the reader a broad perspective almost from the beginning of time for how vitamin D evolved to became intimately involved in the evolution of land vertebrates. It was the deficiency of sunlight causing the devastating skeletal disease known ...

Tópico(s): Vitamin C and Antioxidants Research

2023 - Multidisciplinary Digital Publishing Institute | Nutrients

Revisão Acesso aberto Revisado por pares

Michael F. Holick, Luciana Mazzei, Sebastián García Menéndez, Virna Margarita Martín Giménez, Fatme Al Anouti, Walter Manucha,

Vitamin D (vit D) is widely known for its role in calcium metabolism and its importance for the bone system. However, various studies have revealed a myriad of extra-skeletal functions, including cell differentiation and proliferation, antibacterial, antioxidant, immunomodulatory, and anti-inflammatory properties in various cells and tissues. Vit D mediates its function via regulation of gene expression by binding to its receptor (VDR) which is expressed in almost all cells within the body. This review ...

Tópico(s): Digestive system and related health

2023 - Multidisciplinary Digital Publishing Institute | Nutrients

Revisão Acesso aberto Revisado por pares

Esteban Jódar, Claudia Campusano, Renate T. de Jongh, Michael F. Holick,

In addition to the role of vitamin D in bone mineralization, calcium and phosphate homeostasis, and skeletal health, evidence suggests an association between vitamin D deficiency and a wide range of chronic conditions. This is of clinical concern given the substantial global prevalence of vitamin D deficiency. Vitamin D deficiency has traditionally been treated with vitamin D3 (cholecalciferol) or vitamin D2 (ergocalciferol). Calcifediol (25-hydroxyvitamin D3) has recently become available more widely. ...

Tópico(s): Parathyroid Disorders and Treatments

2023 - Springer Science+Business Media | European Journal of Nutrition